138 related articles for article (PubMed ID: 36588425)
1. Overcoming the Stromal Barrier of the Cornea with a Peptide Conjugate Nano-Assembly to Combat Fungal Keratitis.
Ju X; Wu L; Gao N; Tian Y; Lu G; Gao Y; Zhao S; Niu Z; Yang R
Adv Healthc Mater; 2023 Apr; 12(10):e2202409. PubMed ID: 36588425
[TBL] [Abstract][Full Text] [Related]
2. The preparation and therapeutic effects of β-glucan-specific nanobodies and nanobody-natamycin conjugates in fungal keratitis.
Liu X; Sui J; Li C; Wang Q; Peng X; Meng F; Xu Q; Jiang N; Zhao G; Lin J
Acta Biomater; 2023 Oct; 169():398-409. PubMed ID: 37579912
[TBL] [Abstract][Full Text] [Related]
3. Nanomicelles empower natamycin in treating fungal keratitis: An in vitro, ex vivo and in vivo study.
Sathe P; Kailasam V; Nagarjuna V; Sharma H; Velpandian T; Garg P; Nirmal J
Int J Pharm; 2024 May; 656():124118. PubMed ID: 38615806
[TBL] [Abstract][Full Text] [Related]
4. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
[TBL] [Abstract][Full Text] [Related]
5. Biophilic Positive Carbon Dot Exerts Antifungal Activity and Augments Corneal Permeation for Fungal Keratitis.
Chen H; Geng X; Ning Q; Shi L; Zhang N; He S; Zhao M; Zhang J; Li Z; Shi J; Li J
Nano Lett; 2024 Apr; 24(13):4044-4053. PubMed ID: 38517749
[TBL] [Abstract][Full Text] [Related]
6. Natamycin Ocular Delivery: Challenges and Advancements in Ocular Therapeutics.
Mascarenhas M; Chaudhari P; Lewis SA
Adv Ther; 2023 Aug; 40(8):3332-3359. PubMed ID: 37289410
[TBL] [Abstract][Full Text] [Related]
7. Cell penetrating peptides as efficient nanocarriers for delivery of antifungal compound, natamycin for the treatment of fungal keratitis.
Jain A; Shah SG; Chugh A
Pharm Res; 2015 Jun; 32(6):1920-30. PubMed ID: 25467959
[TBL] [Abstract][Full Text] [Related]
8. [Fungal keratitis caused by Scedosporium apiospermum: first report from Turkey].
Kalkan Akçay E; Açıkgöz ZC; Can ME; Celikbilek N; Dereli Can G; Cağıl N
Mikrobiyol Bul; 2013 Oct; 47(4):727-33. PubMed ID: 24237443
[TBL] [Abstract][Full Text] [Related]
9. Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis.
Roy G; Galigama RD; Thorat VS; Mallela LS; Roy S; Garg P; Venuganti VVK
Int J Pharm; 2019 Dec; 572():118808. PubMed ID: 31678387
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.
Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J
Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325
[TBL] [Abstract][Full Text] [Related]
11. Fungal keratitis caused by Scopulariopsis brevicaulis treated successfully with natamycin.
Malecha MA
Cornea; 2004 Mar; 23(2):201-3. PubMed ID: 15075891
[TBL] [Abstract][Full Text] [Related]
12. Thermosensitive Tri-Block Polymer Nanoparticle-Hydrogel Composites as Payloads of Natamycin for Antifungal Therapy Against
Sha X; Chan L; Fan X; Guo P; Chen T; Liu L; Zhong J
Int J Nanomedicine; 2022; 17():1463-1478. PubMed ID: 35378880
[TBL] [Abstract][Full Text] [Related]
13. Enhanced in vivo antifungal activity of novel cell penetrating peptide natamycin conjugate for efficient fungal keratitis management.
Rohira H; Shankar S; Yadav S; Shah SG; Chugh A
Int J Pharm; 2021 May; 600():120484. PubMed ID: 33737097
[TBL] [Abstract][Full Text] [Related]
14. Curvularia keratitis.
Wilhelmus KR; Jones DB
Trans Am Ophthalmol Soc; 2001; 99():111-30; discussion 130-2. PubMed ID: 11797300
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic therapy of mycotic keratitis.
Sahay P; Singhal D; Nagpal R; Maharana PK; Farid M; Gelman R; Sinha R; Agarwal T; Titiyal JS; Sharma N
Surv Ophthalmol; 2019; 64(3):380-400. PubMed ID: 30797882
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro investigations of fungal keratitis caused by Colletotrichum gloeosporioides.
Mitani A; Shiraishi A; Uno T; Miyamoto H; Hara Y; Yamaguchi M; Ohashi Y
J Ocul Pharmacol Ther; 2009 Dec; 25(6):563-5. PubMed ID: 20028265
[TBL] [Abstract][Full Text] [Related]
17. Antifungal chemotherapy for fungal keratitis guided by in vivo confocal microscopy.
Shi W; Li S; Liu M; Jin H; Xie L
Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):581-6. PubMed ID: 18071734
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
Edwar L; Janna YM; Rozaliyani A; Louisa M
Mycoses; 2020 Oct; 63(10):1128-1132. PubMed ID: 32780874
[TBL] [Abstract][Full Text] [Related]
19. Solid Dispersion Incorporated into Dissolving Microneedles for Improved Antifungal Activity of Amphotericin B:
Mahfud MAS; Syahirah NA; Akram M; Mahfufah U; Saputra MD; Elim D; Andi MNF; Sultan NAF; Himawan A; Domínguez-Robles J; Pamornpathomkul B; Mir M; Permana AD
Mol Pharm; 2023 Dec; 20(12):6246-6261. PubMed ID: 37975721
[TBL] [Abstract][Full Text] [Related]
20. Fungal keratitis after nonpenetrating glaucoma surgery.
Tamcelik N; Ozdamar A; Kizilkaya M; Devranoglu K; Ustundag C; Demirkesen C
Cornea; 2002 Jul; 21(5):532-4. PubMed ID: 12072733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
